EA200870158A1 - Лечение вич - Google Patents

Лечение вич

Info

Publication number
EA200870158A1
EA200870158A1 EA200870158A EA200870158A EA200870158A1 EA 200870158 A1 EA200870158 A1 EA 200870158A1 EA 200870158 A EA200870158 A EA 200870158A EA 200870158 A EA200870158 A EA 200870158A EA 200870158 A1 EA200870158 A1 EA 200870158A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hiv treatment
peptides
hiv
proopiomelanocortin
pomc
Prior art date
Application number
EA200870158A
Other languages
English (en)
Other versions
EA015924B1 (ru
Inventor
Дейрдр Макинтош
Original Assignee
Эймско Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эймско Лимитед filed Critical Эймско Лимитед
Publication of EA200870158A1 publication Critical patent/EA200870158A1/ru
Publication of EA015924B1 publication Critical patent/EA015924B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Описываются способы лечения ВИЧ с помощью пептидов проопиомеланокортина (РОМС) и кортикотропинвысвобождающего фактора (CRF) и их продуктов, а также применение таких пептидов для получения лекарственных средств.
EA200870158A 2006-01-06 2007-01-05 Лечение вич EA015924B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600202.6A GB0600202D0 (en) 2006-01-06 2006-01-06 Treatment of HIV
PCT/GB2007/050006 WO2007077465A2 (en) 2006-01-06 2007-01-05 Treatment of hiv

Publications (2)

Publication Number Publication Date
EA200870158A1 true EA200870158A1 (ru) 2008-12-30
EA015924B1 EA015924B1 (ru) 2011-12-30

Family

ID=35911459

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870158A EA015924B1 (ru) 2006-01-06 2007-01-05 Лечение вич

Country Status (16)

Country Link
US (4) US20090291060A1 (ru)
EP (1) EP1968624A2 (ru)
JP (1) JP5180095B2 (ru)
KR (2) KR20080098488A (ru)
CN (1) CN101394862A (ru)
AP (1) AP2913A (ru)
AU (1) AU2007203991B2 (ru)
BR (1) BRPI0706311A2 (ru)
CA (1) CA2635562A1 (ru)
EA (1) EA015924B1 (ru)
GB (1) GB0600202D0 (ru)
IL (1) IL192618A (ru)
MX (1) MX2008008768A (ru)
NZ (1) NZ569604A (ru)
WO (1) WO2007077465A2 (ru)
ZA (1) ZA200806505B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010054446A1 (en) * 2008-11-11 2010-05-20 Ademovic Zlatko Combination of two or more peptides in a single stable lyophilized pharmaceutical compound
JP5717030B2 (ja) * 2009-02-24 2015-05-13 学校法人金沢医科大学 有核赤血球の脱核方法及び脱核誘導剤
US20130344102A1 (en) * 2012-06-25 2013-12-26 Aimsco Limited Formulation
EP2701728B1 (en) 2012-06-25 2015-05-06 Aimsco Limited Formulation comprising crh and alpha-2-macroglobulin
GB201617175D0 (en) * 2016-10-10 2016-11-23 Iconic Intellectual Property Limited Assay
US11285192B2 (en) * 2019-03-13 2022-03-29 Adamis Pharmaceuticals Corporation Formulation including a combination of beta-endorphin and adrenocorticotropic hormone
MX2021010989A (es) * 2019-03-13 2021-10-01 Adamis Pharmaceuticals Corp Formulacion que incluye una combinacion de la hormona beta-endorfina y adrenocorticotropica.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801612A (en) * 1986-07-03 1989-01-31 Regents Of The University Of California Method of inhibiting inflammatory response
US5137871A (en) * 1989-07-28 1992-08-11 Regents Of The University Of California Treatment to reduce edema for brain and musculature injuries
CN1301729A (zh) * 1999-12-24 2001-07-04 上海博德基因开发有限公司 一种新的多肽——促肾上腺皮质激素释放因子13和编码这种多肽的多核苷酸
WO2002007760A2 (en) * 2000-07-21 2002-01-31 Ice Biologics Limited Therapeutic agent against aids comprising anti hiv goat antibody
CN1361180A (zh) * 2000-12-26 2002-07-31 上海博德基因开发有限公司 一种新的多肽——促肾上腺皮质激素释放因子8.8和编码这种多肽的多核苷酸
ATE282426T1 (de) * 2001-02-24 2004-12-15 Mologen Ag Beta-endorphin / crf - gentherapie zur lokalen schmerzbekämpfung
DE60237447D1 (de) * 2001-07-02 2010-10-07 Aimsco Ltd Verwendung von polyklonalen anti-hiv ziegenseren als therapeutisches mittel
EP1469882B1 (en) * 2002-01-28 2010-08-25 Aimsco Limited Treatment of nervous system diseases with goat serum
BRPI0513062A (pt) * 2004-07-08 2008-04-22 Aimsco Ltd composição farmacêutica, método de estimular a produção de pomc em um paciente, usos de um peptìdeo de crf isolado e de um peptìdeo de pomc isolado, e, métodos de tratamento para uma doença, de produzir crf e de tratamento curativo, melhorador ou profilático de uma doença
GB0509052D0 (en) * 2005-05-04 2005-06-08 Aimsco Ltd Combination therapy

Also Published As

Publication number Publication date
EA015924B1 (ru) 2011-12-30
BRPI0706311A2 (pt) 2011-03-22
AP2913A (en) 2014-05-31
KR20140114443A (ko) 2014-09-26
AP2008004560A0 (en) 2008-08-31
MX2008008768A (es) 2008-09-11
KR20080098488A (ko) 2008-11-10
US20140072530A1 (en) 2014-03-13
AU2007203991A1 (en) 2007-07-12
CA2635562A1 (en) 2007-07-12
US20090291060A1 (en) 2009-11-26
EP1968624A2 (en) 2008-09-17
CN101394862A (zh) 2009-03-25
AU2007203991B2 (en) 2013-01-17
JP2009522345A (ja) 2009-06-11
WO2007077465A2 (en) 2007-07-12
GB0600202D0 (en) 2006-02-15
WO2007077465A3 (en) 2007-11-08
US20130210710A1 (en) 2013-08-15
JP5180095B2 (ja) 2013-04-10
NZ569604A (en) 2011-01-28
IL192618A0 (en) 2009-02-11
IL192618A (en) 2012-06-28
US20120208745A1 (en) 2012-08-16
ZA200806505B (en) 2009-05-27

Similar Documents

Publication Publication Date Title
CY1125029T1 (el) Τροποποιημενοι νουκλεοζιτες, νουκλεοτιδια, και νουκλεϊκα οξεα και χρησεις αυτων
EA200870158A1 (ru) Лечение вич
WO2007048042A3 (en) Small molecule inhibitors of hiv-1 capsid assembly
CL2008001234A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
EA201401281A1 (ru) D-аминокислотные химические соединения для лечения заболеваний печени
WO2006101387A3 (en) Method for interfering with blood coagulation by modulating cross-beta structures fibril formation
AU2012249274A8 (en) Neutralizing antibodies to Nipah and Hendra virus
PE20142463A1 (es) Modulacion de la expresion del transductor de senales y activador de la transcripcion 3 (stat3)
CY1119410T1 (el) Βελτιστοποιημενα μονοκλωνικα αντισωματα εναντι του αναστολεα της οδου του ιστικου παραγοντα (tfpi)
EA201070888A1 (ru) Антитела и их производные
MX2011002966A (es) Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona).
EA201791850A1 (ru) Борсодержащие малые молекулы
DOP2011000333A (es) Inmunoglobulina con dominio variable dual y usos de la mismas
BR112013005116A2 (pt) moduladores e métodos de uso
EA200802182A1 (ru) Модифицированные гуманизированные антитела против интерлейкина-18
EA201491447A1 (ru) Ендиины, их конъюгаты и способы их получения и применения
BR112013014119A8 (pt) Novos moduladores e métodos de uso
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201270662A1 (ru) Связывающие элементы для человеческого цитамегаловируса
EA201001288A1 (ru) Лечение гипертонии 25-гидроксивитамином d3
WO2010017355A3 (en) Small molecule inhibitors of retroviral assembly and maturation
ATE548454T1 (de) Nukleinsäurewirkstoffe zur stilllegung von h19 zwecks behandlung rheumatoider arthritis
EA200701592A1 (ru) Композиты и способы их получения и использования
UY32715A (es) Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados
CY1116374T1 (el) Θεραπεια για τη λοιμωξη με τον ιο της ηπατιτιδας β μονο ή σε συνδυασμο με τον ιο της ηπατιτιδας δελτα και σχετιζομενες ασθενειες του ηπατος

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU